Psychosocial interventions for psychostimulant misuse

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 11, 2015, Pages

  Minozzi, Silvia ^a   De Crescenzo, Franco ^b   Saulle, Rosella ^a   Amato, Laura ^a  

^a DEPARTMENT OF EPIDEMIOLOGY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; COCAINE; ILLICIT DRUG; PSYCHOSTIMULANT AGENT;

AMPHETAMINE DEPENDENCE; ARTICLE; BEHAVIOR THERAPY; COCAINE DEPENDENCE; COGNITIVE BEHAVIORAL THERAPY; COGNITIVE THERAPY; COMMUNITY REINFORCEMENT APPROACH; CONTINGENCY MANAGEMENT; DRUG MISUSE; HUMAN; INTERPERSONAL THERAPY; MOTIVATIONAL INTERVIEWING; PRIORITY JOURNAL; PSYCHODYNAMIC PSYCHOTHERAPY; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; SYSTEMATIC REVIEW; TWELVE STEP FACILITATION;

EID: 84989193511     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD011866     Document Type: Article

References (60)

1. Amato L, Minozzi S, Davoli M, Vecchi S. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database of Systematic Reviews 2011, Issue 10. [DOI: 10.1002/14651858.CD004147.pub4]
2. Amato L, Minozzi S, Davoli M, Vecchi S. Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. Cochrane Database of Systematic Reviews 2011, Issue 9. [DOI: 10.1002/14651858.CD005031.pub4]
3. Atkinson A, Anderson Z, Hughes K, Bellis MA, Sumnall H, et al. Interpersonal violence and illicit drugs. Centre for Public Health, Liverpool John Moores University, Liverpool, UK. 2009 http://www.who.int/violenceprevention/interpersonal_violence:and_illicit_drug_use.pdf (accessed 18 November 2014).
4. Beck JS. Cognitive Behavior Therapy: Basics and Beyond. 2nd Edition. New York: Guilford Press, 2011.
5. Bickel WK, Amass L, Higgins ST, Badger GJ, Esch RA. Effects of adding behavioral treatment to opioid detoxification with buprenorphine. Journal of Consulting and Clinical Psychology 1997;65(5):803-10.
6. Bryck RL, Fisher PA. Training the brain: practical applications of neural plasticity from the intersection of cognitive neuroscience, developmental psychology, and prevention science. American Psychologist 2012;67(2):87-100.
7. Carroll KM, Onken LS. Behavioral therapies for drug abuse. American Journal of Psychiatry 2005;162(8):1452-60.
8. Castells X, Casas M, Pérez-Mañá C, Roncero C, Vidal X, Capellà D. Efficacy of psychostimulant drugs for cocaine dependence. Cochrane Database of Systematic Reviews 2010, Issue 2. [DOI: 10.1002/14651858.CD007380.pub3]
9. Chappel JN, DuPont RL. Twelve-step and mutual-help programs for addictive disorders. Psychiatric Clinics of North America 1999;22(2):425-46.
10. Conner KR, Pinquart M, Holbrook AP. Meta-analysis of depression and substance use and impairment among cocaine users. Drug and Alcohol Dependence 2008;98(1-2):13-23.
11. Cornish JW, O'Brien CP. Crack cocaine abuse: an epidemic with many public health consequences. Annual Review of Public Health 1996;17:2559-73.
12. Cregler LL. Adverse health consequences of cocaine abuse. Journal of the National Medical Association 1989;81:27-38.
13. Dackis CA, O'Brien CP. Cocaine dependence: a disease of the brain' reward centers. Journal of Substance Abuse Treatment 2001;21(3):111-7.
14. Darke S, Kaye S. Attempted suicide among injecting and non injecting cocaine users in Sydney, Australia. Journal of Urban Health 2004;81:505-15.
15. De Leon G. Therapeutic communities for addictions: a theoretical framework. International Journal of the Addictions 1995;30(12):1603-45.
16. Degenhardt L, Day C, Hall W, Conroy E, Gilmour S. Was an increase in cocaine use among injecting drug users in New South Wales, Australia, accompanied by an increase in violent crime?. BMC Public Health 2005;5:40.
17. Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012;379:55-70.
18. Degenhardt L, Whiteford H, Ferrari AJ, Baxter A, Charlson F, Hall W, et al. The global burden of disease attributable to illicit drug use and dependence: results from the GBD 2010 study. Lancet 2013;382:1564-74.
19. Degenhardt L, Baxter AJ, Lee YY, Halle W, Grant E, Sarad GE, et al. The global epidemiology and burden of psychostimulant dependence: findings from the Global Burden of Disease Study 2010. Drug and Alcohol Dependence 2014;137:36-47.
20. Falck RS, Wang J, Siegal HA, Carlson RG. Current physical health problems and their predictors among a community sample of crack-cocaine smokers in Ohio. Journal of Psychoactive Drugs 2003;35:471-8.
21. Feldstein Ewing SW, Filbey FM, Sabbineni A, Chandler LD, Hutchison KE. How psychosocial alcohol interventions work: a preliminary look at what FMRI can tell us. Alcoholism, Clinical and Experimental Research 2011;35(4):643-51.
22. Ferri M, Amato L, Davoli M. Alcoholics Anonymous and other 12-step programmes for alcohol dependence. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD005032.pub2]
23. Gawin FH, Ellinwood EH Jr. Cocaine and other stimulants. Actions, abuse, and treatment. New England Journal of Medicine 1988;318(18):1173-82.
24. The GRADE working group. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490-4.
25. Greene SL, Kerr F, Braitberg G. Review article: amphetamines and related drugs of abuse. Emergency Medicine Australasia 2008;20(5):391-402.
26. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7560):924-6.
27. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64:383-94.
28. Haasen C, Prinzleve M, Gossop M, Fischer G, Casas M, the Cocaine EU-Team. Relationship between cocaine use and mental health problems in a sample of European cocaine powder or crack users. World Psychiatry 2005;4:173-6.
29. Hall SM, Cooper JL, Burmaster S, Polk A. Contingency contracting as a therapeutic tool with methadone maintenance clients: six single subject studies. Behaviour Research and Therapy 1977;15(5):438-41.
30. Hettema J, Steele J, Miller WR. Motivational interviewing. Annual Review of Clinical Psychology 2005;1:91-111.
31. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
32. Kaye S, Darke S. Injecting and non-injecting cocaine use in Sydney, Australia: physical and psychological morbidity. Drug and Alcohol Review 2004;23:391-8.
33. Klimas J, Tobin H, Field CA, O'Gorman CS, Glynn LG, Keenan E, et al. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users. Cochrane Database of Systematic Reviews 2014, Issue 12. [DOI: 10.1002/14651858.CD009269.pub3]
34. Knapp WP, Soares BG, Farrel M, Lima MS. Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD003023.pub3]
35. Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology 2010;35(1):217-38.
36. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
37. Marzuk PM, Tardiff K, Leon AC, Stajic M, Morgan EB, Mann JJ. Prevalence of cocaine use among residents of New York City who committed suicide during a one-year period. American Journal of Psychiatry 1992;149:371-5.
38. Mathers B, Degenhardt M, Phillips L, Wiessing B, Hickman L, Strathdee M, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008;371:1733-45.
39. McKetin R, Kelly E, McLaren J. The relationship between crystalline methamphetamine use and methamphetamine dependence. Drug and Alcohol Dependence 2006;85:198-204.
40. Miller WR, Zweben A, DiClemente CC, Rychtarik RG. Motivational Enhancement Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals with Alcohol Abuse and Dependence. Volume 2, Project MATCH Monograph Series. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism, 1992.
41. Miller WR, Yahne CE, Tonigan JS. Motivational interviewing in drug abuse services: a randomized trial. Journal of Consulting and Clinical Psychology 2003;71:754-63.
42. Minozzi S, Amato L, Davoli M, Farrell M, Lima Reisser AA, Pani PP, et al. Anticonvulsants for cocaine dependence. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD006754.pub4]
43. Mooney M, Sofuoglu M, Dudish-Poulsen S, Hatsukami DK. Preliminary observations of paranoia in a human laboratory study of cocaine. Addictive Behaviors 2006;31:1245-54.
44. NICE Drug Misuse: Psychosocial Interventions. NICE clinical guideline 51. Available at www.nice.org.uk/CG51 [NICE guideline] 2007.
45. Pani PP, Trogu E, Vacca R, Amato L, Vecchi S, Davoli M. Disulfiram for the treatment of cocaine dependence. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD007024.pub2]
46. Rawson RA, Huber A, McCann M, Shoptaw S, Farabee D, Reiber C, et al. A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Archives of General Psychiatry 2002;59(9):817-24.
47. Ribeiro M, Dunn J, Sesso R, Dias AC, Laranjeira R. Causes of death among crack cocaine users. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil: 1999) 2006;28:196-202.
48. Roozen HG, Boulogne JJ, van Tulder MW, van den Brink W, De Jong CA, Kerkhof AJ. A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction. Drug and Alcohol Dependence 2004;74(1):1-13.
49. Roy A. Characteristics of cocaine-dependent patients who attempt suicide. American Journal of Psychiatry 2001;158:1215-9.
50. Schünemann HJ, Jaeschke R, Cook D, Bria W, El-Solh A, Ernst A, et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. American Journal of Respiratory and Critical Care Medicine 2006;174:605-14.
51. Shedler J. The efficacy of psychodynamic psychotherapy. American Psychologist 2010;65(2):98-109.
52. Shoptaw S, Klausner JD, Reback CJ, Tierney S, Stansell J, Hare CB, et al. A public health response to the methamphetamine epidemic: the implementation of contingency management to treat methamphetamine dependence. BMC Public Health 2006;6:214.
53. Smedslund G, Berg RC, Hammerstrøm KT, Steiro A, Leiknes KA, Dahl HM, et al. Motivational interviewing for substance abuse. Cochrane Database of Systematic Reviews 2011, Issue 5. [DOI: 10.1002/14651858.CD008063.pub2]
54. UNODC Ecstasy and amphetamines: Global Survey 2003. Vienna United Nations Publication Sales No. E.03.XI.15 ISBN 92-1-148164-3). ISBN 92-1-148164-3. Vol. Sales No. E.03.XI.15, Vienna: United Nations Publication, 2003.
55. United Nations Office on Drugs and Crime. World Drug Report. Vienna: United Nations Office on Drugs and Crime, 2012.
56. United Nations Office on Drugs and Crime. World Drug Report. Vienna: United Nations Office on Drugs and Crime, 2014.
57. van Schaik A, van Marwijk H, Adèr H, van Dyck R, de Haan M, Penninx B, et al. Interpersonal psychotherapy for elderly patients in primary care. American Journal of Geriatric Psychiatry 2006;14(9):777-86.
58. Volkow N, Fowler J, Wang GJ, Swanson J. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Molecular Psychiatry 2004;9:557-69.
59. WHO Lexicon of alcohol and drug terms published by the World Health Organization. http://www.who.int/substance:abuse/terminology/who_lexicon/en/.
60. Worhunsky PD, Stevens MC, Carroll KM, Rounsaville BJ, Calhoun VD, Pearlson GD, et al. Functional brain networks associated with cognitive control, cocaine dependence, and treatment outcome. Psychology of Addictive Behaviors 2013;27(2):477-88.